May Hill Capital’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
May Hill Capital's HAE Position: Q3 2026 in Review
May Hill Capital increased its Haemonetics (HAE) stake by 12% in Q3 2026, buying an estimated $252K and bringing the position to 25,093 shares worth $2.64M. The position accounts for 0.52% of the portfolio, ranked #38.
May Hill Capital first reported a position in HAE in Q4 2024 and has held it in 8 quarters since. 358 funds tracked by Wall St. Rank hold HAE as of Q3 2026.
- May Hill Capital held 25,093 shares of Haemonetics worth $2.64M as of Q3 2026.
- May Hill Capital bought 2,705 Haemonetics shares in Q3 2026, an estimated $252K.
- Haemonetics made up 0.52% of May Hill Capital's portfolio in Q3 2026, its #38 holding.
- May Hill Capital first reported a position in Haemonetics in Q4 2024 and has held it in 8 quarters since.
- 358 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.
Based on May Hill Capital's 13F filing for Q3 2026, filed 3 Nov 2026.